KEPPRA SUMMARY
KEPPRA® (levetiracetam)
mg, 500 mg, 750 mg, and 1000 mg tablets
mg/mL oral solution
Keppra® (levetiracetam) is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow) and 750 mg (orange) tablets and as a clear, colorless, grape-flavored liquid (100 mg/mL) for oral administration.
Keppra® (levetiracetam) is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy.
|
KEPPRA NEWS HIGHLIGHTS
Media Articles Related to Keppra (Levetiracetam)
Keppra XR Approved for Partial-Onset Seizures
Source: MedicineNet Seizure Specialty [2008.09.16]
Keppra XR(TM) Approved In The U.S. As Add-On To Other Antiepileptic Treatments For People With Partial Onset Seizures
Source: Epilepsy News From Medical News Today [2008.09.15]
The First Direct Structural Evidence Of SV2A Has Been Revealed Thanks To Protein Tomography(TM), And Published In BBRC
Source: Epilepsy News From Medical News Today [2008.09.10]
New Data Show Efficacy Of Zebinix(TM) In The Treatment Of Epilepsy
Source: Epilepsy News From Medical News Today [2008.09.25]
Clues To Autism, Epilepsy, Mental Retardation From Rare Genetic Disorder
Source: Autism News From Medical News Today [2008.09.24]
Published Studies Related to Keppra (Levetiracetam)
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. [2008.07.24]
Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study. [2008.06]
Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. [2008.04]
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. [2008.02.19]
Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures. [2008.02]
Clinical Trials Related to Keppra (Levetiracetam)
Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-Maintained Patients. [Completed]
A Study Of The Safety And Efficacy Of Levetiracetam (Keppraź) (Ucb L059) In Children With Epilepsy [Completed]
Long Term Follow-up Study With Levetiracetam XR (Keppra XR) for Partial Seizures [Enrolling by invitation]
A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy [Completed]
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy [Completed]
|
